4.5 Article

Can charcoal improve outcomes in COVID-19 infections?

Journal

MEDICAL HYPOTHESES
Volume 144, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.mehy.2020.110176

Keywords

-

Funding

  1. National Institutes of Health [HL109015, HL071556, HL105649, HL55601, HL34300]
  2. COBRE ACCORD grant [1P20GM121299]
  3. BrickStreet Foundation
  4. Huntington Foundation, Inc.

Ask authors/readers for more resources

COVID-19 infection causes considerable morbidity and mortality, especially to those who are aged, have impaired renal function and are obese. We propose to examine the potential utility of oral activated charcoal with the hypothesis that such treatment would lower absorption of microbiome derived toxins and ameliorate systemic oxidant stress and inflammation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available